| R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience S Bašić-Kinda, I Radman, D Dujmović, I Ilić, M Kralik, M Dobrenić, ... Annals of hematology 100 (6), 1517-1524, 2021 | 9 | 2021 |
| Infradiaphragmal radiotherapy in patients with lymphoma: volume definition and side effects L Galunić Bilić, F Šantek Acta clinica Croatica 57 (3.), 554-560, 2018 | 4 | 2018 |
| Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: A single-centre experience L Galunic Bilic, F Santek, JJ Grah, S Basic-Kinda, I Mandac Smoljanovic, ... La radiologia medica 128 (4), 492-500, 2023 | 1 | 2023 |
| Substituting doxorubicin with etoposide in R-CHOP results in a regimen with similar efficacy for treatment of newly diagnosed elderly patients with B-large cell lymphoma (B-LCL) I Hude, S Basic-Kinda, I Radman, S Dotlic, M Kralik, M Vodanovic, ... HAEMATOLOGICA 102, 399-399, 2017 | 1 | 2017 |
| Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP) I Hude Dragičević, S Bašić-Kinda, H Markotić, M Morić-Perić, D Dujmović, ... Medicina 60 (3), 430, 2024 | | 2024 |
| Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience L Galunic Bilic, F Santek, Z Mitrovic, S Basic-Kinda, D Dujmovic, ... Cancers 16 (3), 649, 2024 | | 2024 |
| Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma V Premužić, S Bašić-Kinda, I Radman, D Dujmović, I Ilić, N Živković, ... Medicine 102 (20), e33675, 2023 | | 2023 |
| P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) IH Dragičević, S Bašić-Kinda, D Dujmović, I Radman, B Dreta, S Dotlić, ... HemaSphere 6, 8, 2022 | | 2022 |
| Reduced steroid exposure is safe and does not reduce disease control among Hodgkin lymphoma patients treated with escalated BEACOPP (eBEACOPP) I Hude Dragičević, S Bašić-Kinda, D Dujmović, I Radman, B Dreta, ... 12th International Symposium on Hodgkin Lymphoma, 8-9, 2022 | | 2022 |
| Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients L Galunić Bilić, F Šantek, M Soče, JJ Grah, S Bašić Kinda, I Radman, ... ESTRO 2020 Translating research and partnership into optimal health, S486-S486, 2020 | | 2020 |
| Učinkovitost i nuspojave radioterapije infradijafragmalnih polja u bolesnika s limfomima L Galunić Bilić University of Zagreb. School of Medicine, 2019 | | 2019 |
| Učinkovitost i nuspojave radioterapije infradijafragmalnih polja u bolesnika s limfomima [The efficancy and the side-effects of infradiaphragmal radiotherapy fields in patients … L Galunić Bilić Sveučilište u Zagrebu, 2019 | | 2019 |
| eBEACOPP for front-line treatment of patients with classical Hodgkin lymphoma (cHL) in the real world setting S Basic-Kinda, D Dujmovic, I Radman, M Moric Peric, I Hude, N Durakovic, ... 11th International Symposium on Hodgkin Lymphoma, 26-26, 2018 | | 2018 |
| THE SWITCH FROM ABVD TO eBEACOPP AS FRONT-LINE THERAPY FOR HIGH-RISK STAGE III-IV CLASSICAL HODGKIN LYMPHOMA PATIENTS RESULTS IN AN INVERSION OF EVENT-FREE SURVIVAL OF … I Aurer, S Basic-Kinda, D Dujmovic, I Radman, B Dreta, S Dotlic, ... HAEMATOLOGICA 101, 24-24, 2016 | | 2016 |
| The switch from ABVD to eBEACOPP as front-line therapy for high-risk patients stage III-IV Hodgkin lymphoma (CHL) patients results in an inversion of event-free survival (EFS … I Aurer, S Basic-Kinda, D Dujmovic, I Radman, B Dreta, S Dotlic, ... 10th International Symposium on Hodgkin Lymphoma, 24-24, 2016 | | 2016 |
| TEMOZOLOMIDE AND ITS ROLE IN THE TREATMENT OF MALIGNANT GLIOMAS A Mišir Krpan, A Juretić, F Šantek, L Galunić Bilić, Z Rakušić, JJ Grah, ... Paediatria Croatica 57 (1), 2013 | | 2013 |
| Mezenhimalni hondrosarkom-terapijski izazov L Galunić Bilić, Z Krajina, A Juretić, V Dekleva, K Lončar, L Jajac Bručić, ... Paediatria Croatica 57 (1), 2013 | | 2013 |
| Indikacije za sustavno liječenje i radioterapiju lokoregionalnog recidiva poslije liječenja karcinoma s očuvanjem dojke A Juretić, Z Rendić-Miočević, N Šarić, M Bašić-Koretić, L Galunić-Bilić, ... XXIII. znanstveni sastanak" Bolesti dojke", 193-202, 2013 | | 2013 |
| Prikaz slučaja bolesnice s karcinom dojke koji se inicijalno manifestirao presadnicom u žilnicu lijevog oka L Jajac, Z Rakušić, L Galunić Bilić, K Lončar, A Juretić Peti hrvatski onkološki kongres s međunarodnim sudjelovanjem, 82-82, 2010 | | 2010 |
| Antunac Golubić, Zrna 41 K Antunac, I Babić, I Badovinac, Ž Bajić, A Barić Žižić, M Bašić Koretić, ... | | |
